Try our Advanced Search for more refined results

Expert Analysis

Nexium Case Begins To Define Contours Of Actavis Decision

Law360, New York (September 27, 2013, 11:52 AM EDT) -- Recently, a federal judge in Massachusetts largely denied a series of motions seeking dismissal of various "pay-for-delay" claims brought by direct and indirect purchasers involving AstraZeneca PLC's acid reflux drug Nexium. Although certain federal and state claims were trimmed on statute of limitations grounds, U.S. District Judge William Young let stand the core claims of the suit based on the alleged continuing harm flowing from the agreements....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!